Panel Discussion | Rare Disease Diagnosis Odyssey

Did you know that up to 50% of cardiomyopathy cases are due to genetic causes but only 1% of patients get genetically tested? Genetic testing is available but not widely utilized. Hear from a patient with BAG3-associated dilated cardiomyopathy (DCM), which is a rare, genetically driven form of heart failure, a patient advocate, and a genetic counselor on why that can impact families, how to get genetic testing, and where to look for resources.
Disease Overview | Dilated Cardiomyopathy (DCM)
Matthew Coggins, MD, Senior Medical Director, AAV, Rocket Pharma
Panelists:
Becky, DCM Patient and Caregiver
Abigail Yesso, MS, Genetic Counselor, Texas Childrens
Greg Ruf, Executive Director & Board President, DCM Foundation
Moderator: Erika Zannou-Mantri, PharmD, PhD, MBA, SVP, Development Operations & Global Program Head, Rocket Pharma